Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.85 USD
Change Today -0.54 / -7.31%
Volume 1.1M
SNMX On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David B. Berger Esq.

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.

45--

Background*

Mr. David B. Berger, Esq., has been General Counsel of Tandem Diabetes Care, Inc. since August 2013 and has been its Corporate Secretary since January 2015. Mr. Berger served as Senior Vice President, General Counsel and Secretary of Senomyx Inc. since January 2008. Mr. Berger has more than 12 years of experience advising senior management and corporate boards of public and emerging growth companies in biotechnology, medical diagnostics and information technology industries. ...

Read Full Background

Corporate Headquarters*

4767 Nexus Centre Drive
San Diego, California 92121

United States

Phone: 858-646-8300
Fax: 858-404-0752

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
University of California Berkeley
JD
Stanford University Law school

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNMX:US $6.85 USD -0.54

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Becton, Dickinson and Company
$985.0K
Kevin R. Sayer Chief Executive Officer, President and Director
DexCom, Inc.
$325.0K
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
Patrick J. Sullivan Chief Executive Officer, President and Director
Insulet Corporation
$182.5K
Philip Bowman Chief Executive Officer and Executive Director
Smiths Group plc
1.5M GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SENOMYX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.